Background: Metallo-β-lactamases (MBLs) have been reported in gram negative bacilli and are becoming increasingly important clinically because the enzymes hydrolyse almost all β-lactams, including carbapenems. Thus, the present study was conducted to determine the prevalence of MBL types in imipenem-nonsusceptible Pseudomonas aeruginosa and Acinetobacter baumannii isolated from a tertiary teaching hospital. Methods: Imipenem-nonsusceptible strains, 128 P. aeruginosa and 93 A. baumannii, were collected from clinical specimens. Identification and susceptibility tests were determined by Vitek GNI and GNS cards. MBL production was determined by modified Hodge test and imipenem-EDTA synergy test. Multiplex PCR amplification of MBL genes including blaIMP-1, blaVIM-1 and blaVIM-2 were performed. Results: Thirty-one P. aeruginosa (24.2%) isolates and 3 A. baumannii (3.2%) were found to be MBL producers. In P. aeruginosa, 20 (15.6%) and 11 (8.6%) isolates were positive for blaIMP-1 and blaVIM-2, respectively whereas 1 (1.0%) and 2 (2.2%) isolates in A. baumannii, respectively. Conclusion: IMP-1 is more prevalent MBL type than VIM-2 among imipenem-nonsusceptible P. aeruginosa unlike in other studies. Larger numbers of isolates and sequential studies are strongly recommended for the useful evaluation and monitoring of MBL production in the hospital setting to infection-control. 
INTRODUCTION
Carbapenem is the most active antimicrobial agent against both gram negative and positive organisms and is used for the treatment of nosocomial infections especially due to multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii [1] . However, its efficacy is increasingly being limited because carbapenem-resistant isolates are emerging in many regions of the world [2, 3] . The mechanisms for resistance to carbapenems were known to be the combined action of the acquisition of β-lactamases that hydrolyze carbapenems, Ambler class B (metalloenzymes, MBLs) and class D (oxacillinases) enzymes, mutations in genes coding for penicillin-binding proteins and decreased outer membrane permeability or overexpressed efflux pumps [2] . Among class B enzymes IMP and VIM types are frequent MBLs whereas OXA-23, OXA-24 and OXA-58 enzymes are three major subgroups of class D lactamases [4, 5] .
In Korea, recent studies reported imipenem resistance rates among nonfermenters were ranged from 18% up to 40% [6, 7] . Imiepnem resistance rapidly increased from less than 5% in 2002 to 35% in 2009 in our hospital and became a great concern to treat multidrug-resistant P. aeruginosa and A. baumannii. According to the studies of carbapenem resistance, carbapenemase production accounts the most [2, 3] . IMP-1, VIM-2 and OXA-23 are the most frequently encountered enzymes among multidrug-resistant P. aeruginosa and A. baumannii with proportions varied within Korea [8] . Therefore, we conducted this study to evaluate the prevalence and types of MBLs among class B group resulting in carbapenem resistance in our hospital. o C for 7 minutes. Sequencing analysis was then perform to determine specific enzymes of MBLs as described previously [11] sending to the reference laboratory.
MATERIALS AND METHODS
IMP-1R GAACAACCAGTTTTGCCTTACC VIM-1F TCTACATGACCGCGTCTGTC 748 VIM-1R TGTGCTTTGACAACGTTCGC VIM-2F ATGTTCAAACTTTTGAGTAAG 801 VIM-2R CTACTCAACGACTGAGCG
RESULTS
One hundred twenty-eight P. aeruginosa isolates were from sputum (58), urine (45), body fluid (9), wound (7), blood (3), catheter tip (3), and others (3). Ninety-three A. baumannii isolates were from sputum (79), urine (5), wound (4), body fluid (2), catheter tip (2) and throat (1) .
Thirty-one isolates (24.2%) of 128 imipenem-nonsusceptible P.
aeruginosa were found to be MBL producers. Eleven isolates (8.6%) were blaVIM-2 positive and 20 (15.6%) were blaIMP-1 positive (Table 2) . Among 93 imipenem-nonsusceptible A. baumannii, 3 isolates (3.2%) were positive for modified Hodge and imipenem-EDTA synergy test. Gene of blaVIM-2 was positive in 2 A. baumannii isolates and only one was blaIMP-1 positive (Table 3) .
By DNA sequencing analysis of MBL producing strains in P. aeruginosa, 5 out of 20 blaIMP-1 like positive isolates were IMP-6 and the rest were IMP-1. Eleven of blaVIM-2-like positive were VIM-2.
All the blaIMP-1-like and blaVIM-2-like in A. baumannii were IMP-1 and VIM-2, respectively.
DISCUSSION
Carbapenems such as imipenem and meropenem generally represent last resources for the treatment of nosocomial infections produced by multidrug-resistant Gram-negative bacteria due to their broad antimicrobial activity spectrum and stability against most common β-lactamases [12] . However, emergence of resistance to these drugs becomes a threatening for the treatment of Gram-negative bacterial infection worldwide [4, 10] . As the mechanisms of the carbapenem resistance have been studied, they are due to specific reductions in outer membrane permeability, efflux pump, alteration of penicillin-binding proteins and also presence of carbapenem-hydrolysing enzymes [5] . Production of carbapenemases, especially MBLs, is becoming a leading cause of the resistance and considered to be more important than other mechanisms due to the horizontal spread of plasmids [2, 3] .
Ambler class B carbapenemases, MBLs, such as IMP, VIM and SIM are frequently detected enzyme types in imiepnem-resistant P. aeruginosa and A. baumannii in Korea [12] [13] [14] . For class B carbapenem-hydrolysing enzymes, IMP-1 is found out to be more prevalent MBL type than VIM-2 type among imipenem-nonsusceptible P. aeruginosa in our study. The results were consistent with other reports of Daegu and Busan, near city in Korea [14, 15] . We were able to find an outbreak of IMP-6 positive P. aeruginosa retrospectively during this study and reported for the first time in Korea [16] . However, VIM-2 type was the most frequently detected in other regions of Korea [8, 17, 18] . Only three isolates of A. baumannii had MBLs, 2 for VIM-2 and 1 for IMP-1 in this study. Considering that the isolates of imipenem-resistant A. baumannii have increased abruptly in our hospital since 2003, carbapenemases other than MBLs and or other resistant mechanisms could be present and further affect the prevalence of carbapenem nonsusceptibility. It was very regretful that we could not perform any epidemiological studies to determine the clonality of the imipenem-nonsusceptible isolates. Therefore, our infection control committee recently started to surveillance the prevalence and outbreaks since then and to collect the isolates to perform the moleculoepidemiological studies, if possible.
Early recognition of carbapenemase producers among pathogenic isolates and a preliminary characterization of the type of enzyme produced are considered to an essential step for infection control in the hospital. Guiding the use of antibiotics that may favor the spread of carbapenemase producing bacteria also plays an important role in infection-control measures [4] . We give attention to increased prevalence of any multidrug-resistant organisms and also to outbreaks, especially in intensive care units. Larger numbers of isolates including closer districts within Daegu and sequential studies for annual prevalence are strongly recommended for the useful evaluation and monitoring of carbapenemase producing Gram-negative bacteria.
